Fluvastatin

The dosage of fluvastatin is individualized based on the patient's baseline LDL cholesterol levels, the goal of therapy, and the patient's response to treatment.

• Standard Starting Dose: For most adults, the recommended starting dose is 20 mg to 40 mg once daily, taken in the evening.
• Maintenance Range: The dosage may be adjusted by a healthcare provider at intervals of 4 weeks or more. The maximum recommended dose for the immediate-release capsules is 40 mg twice daily (80 mg total).
• Extended-Release (XL): The 80 mg extended-release tablet is typically prescribed as a single daily dose, which can be taken at any time of the day, provided it is taken at the same time consistently.

Fluvastatin is approved for pediatric patients with heterozygous familial hypercholesterolemia (HeFH) between the ages of 9 and 16 years.

• Dosing for Children (9-16 years): The typical starting dose is 20 mg once daily. Based on clinical response and tolerability, the dose may be titrated up to a maximum of 80 mg per day (either as 40 mg capsules twice daily or one 80 mg XL tablet once daily).
• Note: Use in children under the age of 9 has not been established and is generally not recommended.

Renal Impairment

Since fluvastatin is primarily cleared through the liver (biliary excretion), mild to moderate renal impairment usually does not require a dose adjustment. However, for patients with severe renal impairment (creatinine clearance < 30 mL/min), healthcare providers should exercise caution and monitor the patient closely when doses exceed 40 mg per day.

Hepatic Impairment

Fluvastatin is contraindicated in patients with active liver disease or unexplained, persistent elevations in serum transaminases (liver enzymes). In patients with a history of liver disease or heavy alcohol use, the drug should be used with extreme caution.

Elderly Patients

Clinical studies have shown that the efficacy and safety of fluvastatin in patients aged 65 and older are similar to those in younger adults. However, because elderly patients are more likely to have decreased renal function or be taking multiple medications (polypharmacy), they may be at a higher risk for statin-associated muscle symptoms.

• Consistency is Key: Take fluvastatin at the same time every day to maintain steady levels in your bloodstream.
• Food: You may take fluvastatin with or without food. Taking it with a meal may help reduce potential stomach upset.
• Administration: Immediate-release capsules should be swallowed whole. Extended-release (XL) tablets must be swallowed whole and should never be crushed, chewed, or broken, as this destroys the slow-release mechanism and increases the risk of side effects.
• Diet and Exercise: Fluvastatin is meant to supplement, not replace, a heart-healthy diet and regular physical activity. Patients should continue a cholesterol-lowering diet (such as the TLC or DASH diet) throughout treatment.
• Storage: Store the medication at room temperature (20°C to 25°C / 68°F to 77°F), away from moisture, heat, and direct light.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within 12 hours), skip the missed dose and return to your regular dosing schedule. Do not take two doses at once to make up for a missed one, as this increases the risk of toxicity.

In the event of an overdose, seek emergency medical attention or contact a Poison Control Center immediately. While there is no specific antidote for fluvastatin overdose, treatment is generally supportive. Symptoms of overdose may include severe nausea, vomiting, diarrhea, or muscle pain. Healthcare providers will typically monitor liver function and creatine kinase (CK) levels to assess for muscle damage.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop taking the medication without medical guidance, as this may lead to a rapid increase in cholesterol levels.

While fluvastatin is generally well-tolerated, some patients may experience mild side effects as their body adjusts to the medication. These often resolve within a few weeks of starting treatment.

• Gastrointestinal Upset: This includes dyspepsia (indigestion), abdominal pain, and nausea. These symptoms are often mild and can be mitigated by taking the medication with food.
• Headache: One of the most frequently reported side effects. If headaches are persistent or severe, consult your doctor.
• Insomnia: Some patients report difficulty falling or staying asleep, though this is less common with fluvastatin than with more lipophilic statins like simvastatin.

• Myalgia (Muscle Pain): Patients may experience generalized muscle aching or weakness without an elevation in muscle enzymes.
• Sinusitis and Pharyngitis: Inflammation of the sinuses or throat has been reported in clinical trials.
• Accidental Injury: Some clinical data noted a slight increase in reports of minor accidental injuries, though the clinical significance of this is unclear.
• Dizziness: A feeling of lightheadedness or unsteadiness.

• Paresthesia: Tingling or "pins and needles" sensations in the hands or feet.
• Hepatitis: Rare cases of liver inflammation have been documented.
• Thrombocytopenia: A decrease in blood platelet counts, which can lead to easier bruising or bleeding.
• Hypersensitivity Reactions: Including rash, pruritus (itching), and urticaria (hives).

> Warning: Stop taking Fluvastatin and call your doctor immediately if you experience any of these serious symptoms.

1. 1Rhabdomyolysis: This is a rare but life-threatening condition where muscle tissue breaks down, releasing a protein called myoglobin into the blood, which can cause severe kidney damage. Symptoms include severe muscle pain, tenderness, or weakness, especially when accompanied by fever and dark-colored (tea-colored) urine.
2. 2Liver Dysfunction: Signs include yellowing of the skin or eyes (jaundice), dark urine, severe pain in the upper right abdomen, and extreme fatigue.
3. 3Pancreatitis: Severe pain in the upper stomach radiating to the back, accompanied by nausea and vomiting.
4. 4Severe Allergic Reaction (Anaphylaxis): Swelling of the face, lips, tongue, or throat; difficulty breathing; or severe skin peeling (Stevens-Johnson Syndrome).

• Blood Sugar Changes: Like all statins, long-term use of fluvastatin has been associated with a slight increase in HbA1c and fasting blood glucose levels. In some patients, this may lead to the development of Type 2 diabetes. However, the cardiovascular benefits of statins generally outweigh the risk of slightly elevated blood sugar.
• Cognitive Effects: There have been rare, post-marketing reports of memory loss, forgetfulness, and confusion associated with statin use. These symptoms are generally non-serious and reversible upon discontinuation of the drug.
• Persistent Myopathy: In very rare cases, an immune-mediated necrotizing myopathy (IMNM) can occur, characterized by proximal muscle weakness and elevated serum creatine kinase that persists even after stopping the statin.

There are currently no FDA black box warnings for fluvastatin. However, the drug carries strong warnings regarding pregnancy and liver disease, which were previously handled via the highest level of precaution in the labeling.

Report any unusual symptoms to your healthcare provider. It is helpful to keep a diary of any new symptoms that begin after starting fluvastatin to discuss during your follow-up appointments.

Fluvastatin is a potent medication that requires careful medical supervision. Before starting therapy, patients must undergo a thorough medical history review and baseline blood tests. It is essential to understand that while fluvastatin reduces the risk of cardiovascular events, it must be used as part of a comprehensive lifestyle modification program.

No FDA black box warnings for Fluvastatin.

Skeletal Muscle Risks (Myopathy/Rhabdomyolysis)

Fluvastatin, like other statins, can occasionally cause myopathy, defined as muscle pain, tenderness, or weakness with creatine kinase (CK) values above 10 times the upper limit of normal. The risk is dose-dependent and increases with the concurrent use of certain medications (see Interactions). Risk factors include being over age 65, having untreated hypothyroidism, or having renal impairment.

Liver Enzyme Elevations

Persistent elevations in serum transaminases (ALT or AST) have occurred in approximately 1.1% of patients taking 40 mg of fluvastatin and 1.9% of those taking 80 mg. It is recommended that liver function tests be performed before starting treatment and thereafter if symptoms suggestive of liver injury (e.g., fatigue, jaundice, dark urine) occur.

Endocrine Function

Statins interfere with cholesterol synthesis and, theoretically, might blunt adrenal and/or gonadal steroid production. Clinical studies have shown that fluvastatin does not typically reduce basal plasma cortisol concentration or affect adrenal reserve, but caution should be used if a statin is administered with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole.

Central Nervous System (CNS) Vascular Lesions

Although not seen in human fluvastatin trials, CNS vascular lesions (hemorrhages and edema) have been observed in dogs treated with other members of this drug class. Patients should be monitored for any unexplained neurological changes.

To ensure the safety and efficacy of fluvastatin, healthcare providers will typically order the following tests:

• Lipid Panel: Performed at baseline, 4-12 weeks after starting or adjusting the dose, and every 3-12 months thereafter to monitor LDL, HDL, and triglyceride levels.
• Liver Function Tests (LFTs): Specifically ALT and AST, performed before treatment begins and as clinically indicated if symptoms of liver injury appear.
• Creatine Kinase (CK): Not routinely monitored in asymptomatic patients, but required if a patient reports unexplained muscle pain or weakness.
• HbA1c/Blood Glucose: Periodic monitoring is recommended, especially for patients at high risk for developing diabetes.

Fluvastatin is not known to interfere with the ability to drive or operate heavy machinery. However, if you experience dizziness or blurred vision as a side effect, you should avoid these activities until you know how the medication affects you.

Excessive alcohol consumption can increase the risk of liver damage when taking fluvastatin. Patients who consume substantial quantities of alcohol or have a history of liver disease should discuss their habits honestly with their healthcare provider. Most doctors recommend limiting alcohol to no more than one drink per day for women and two for men.

Fluvastatin should be temporarily withheld in any patient experiencing an acute, serious condition suggestive of myopathy or having a risk factor predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., severe sepsis, hypotension, major surgery, trauma, or severe metabolic/endocrine/electrolyte disorders).

> Important: Discuss all your medical conditions, including any history of liver disease, kidney problems, or alcohol use, with your healthcare provider before starting Fluvastatin.

• Active Liver Disease: Fluvastatin should never be used in patients with current liver inflammation or unexplained liver enzyme elevations, as the drug is metabolized in the liver and can exacerbate these conditions.
• Pregnancy: Fluvastatin is contraindicated during pregnancy due to the essential role cholesterol plays in fetal development. Using this drug during pregnancy may cause fetal harm.

• Gemfibrozil and Other Fibrates: Combining fluvastatin with fibrates increases the risk of myopathy and rhabdomyolysis. This combination should generally be avoided unless the benefit of further lipid alteration outweighs the increased risk.
• Cyclosporine: Concurrent use can significantly increase the blood levels of fluvastatin (up to a 2-fold increase), increasing the risk of muscle toxicity. Doses of fluvastatin should not exceed 40 mg daily in these patients.
• Fluconazole: As a potent inhibitor of CYP2C9, fluconazole can increase the exposure (AUC) of fluvastatin by approximately 50-80%. Patients should be monitored closely for muscle pain.

• Warfarin: Fluvastatin may slightly increase the anticoagulant effect of warfarin. Patients on warfarin should have their Prothrombin Time or INR monitored closely when fluvastatin is initiated or the dose is changed.
• Colchicine: Cases of myopathy, including rhabdomyolysis, have been reported with statins co-administered with colchicine. Use with caution.
• Niacin (Nicotinic Acid): The risk of skeletal muscle effects may be enhanced when fluvastatin is used in combination with lipid-modifying doses (≥1 g/day) of niacin.
• Bile Acid Sequestrants (e.g., Cholestyramine): These drugs can bind to fluvastatin in the gut and reduce its absorption. Fluvastatin should be taken at least 2 hours after or 4 hours before taking a bile acid sequestrant.

• Grapefruit Juice: Unlike atorvastatin or simvastatin, fluvastatin is NOT primarily metabolized by CYP3A4. Therefore, grapefruit juice does not have a major clinical interaction with fluvastatin, though moderation is still advised.
• High-Fat Meals: Can delay the time to peak concentration (Tmax) but do not affect the overall absorption (AUC).
• Alcohol: Increases the risk of hepatic (liver) toxicity and should be limited.

• St. John's Wort: May potentially decrease the plasma concentration of fluvastatin by inducing metabolic enzymes, though the effect is typically minor.
• Red Yeast Rice: This supplement contains naturally occurring monacolin K (lovastatin). Taking it with fluvastatin increases the risk of "statin overdose" and muscle damage.
• Coenzyme Q10 (CoQ10): Some patients take CoQ10 to prevent muscle pain. While some studies suggest it may help, clinical evidence is not definitive, and you should consult your doctor before starting it.

Fluvastatin does not typically interfere with standard laboratory tests, but it will significantly alter lipid panel results (which is the intended effect). It may also cause transient elevations in urine protein in some patients, though this is usually not indicative of kidney damage.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs like ibuprofen or cold medicines.

1. 1Hypersensitivity: Patients with a known allergy to fluvastatin or any of the inactive ingredients in the capsules or tablets must not use this medication. Anaphylaxis and angioedema are rare but serious risks.
2. 2Active Liver Disease: This includes conditions such as acute hepatitis or cirrhosis. Because fluvastatin is processed by the liver, impaired liver function can lead to toxic drug accumulation and further organ damage.
3. 3Unexplained Persistent Elevations of Serum Transaminases: If liver enzymes (ALT/AST) are high for unknown reasons, starting a statin is contraindicated until the cause is determined.
4. 4Pregnancy and Nursing: Cholesterol is vital for fetal membrane formation and hormone synthesis. Blocking its production can lead to birth defects. Fluvastatin also passes into breast milk and poses a risk to nursing infants.

• Severe Renal Impairment: While not an absolute contraindication, patients with a CrCl < 30 mL/min require extreme caution and lower starting doses.
• History of Alcohol Abuse: These patients are at a significantly higher risk for statin-induced liver injury.
• Hypothyroidism: Untreated thyroid issues increase the risk of myopathy. Thyroid function should be stabilized before starting statin therapy.
• Elective Surgery: It is often recommended to temporarily stop fluvastatin a few days before major surgery to reduce the risk of rhabdomyolysis during the perioperative period.

While fluvastatin is chemically distinct from fungal-derived statins, patients who have experienced severe myopathy or rhabdomyolysis on one statin are at an increased risk of experiencing it on another. Cross-sensitivity for allergic reactions (rashes) between different statins is possible but not guaranteed.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to cholesterol medications, before prescribing Fluvastatin.

FDA Category X (Traditional): Fluvastatin is contraindicated in pregnancy. Although the FDA has recently requested the removal of the "Category X" label for statins to allow for individualized risk assessment in very high-risk patients (e.g., those with homozygous familial hypercholesterolemia), for the vast majority of patients, the risk to the fetus far outweighs any benefit. If a patient becomes pregnant while taking fluvastatin, the drug should be discontinued immediately, and the patient should be counseled on the potential risks to the fetus.

Based on animal data, fluvastatin is excreted in breast milk. Because of the potential for serious adverse reactions in nursing infants, women taking fluvastatin should not breastfeed. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Fluvastatin is approved for use in children aged 9 to 16 years with heterozygous familial hypercholesterolemia. Clinical trials lasting up to two years showed that the drug was effective in lowering LDL and was well-tolerated, with no significant effects on growth, sexual maturation, or hormone levels. Use in children under 9 years old has not been studied and is not recommended.

In clinical trials, no overall differences in safety or effectiveness were observed between patients over 65 and younger subjects. However, the elderly are more susceptible to myopathy due to factors like reduced muscle mass, multiple comorbidities, and the use of interacting medications. Healthcare providers may choose to start at the lower end of the dosing range for this population.

• Mild to Moderate: No dosage adjustment is necessary for patients with mild to moderate renal impairment.
• Severe (CrCl < 30 mL/min): Limited data exists for this population. Doses above 40 mg should be administered with caution and under close medical supervision.
• Dialysis: Fluvastatin is not significantly removed by hemodialysis. Because it is highly protein-bound, supplemental doses after dialysis are not required.

Fluvastatin is primarily metabolized by the liver. In patients with hepatic insufficiency, the plasma concentration of the drug can increase significantly. It is contraindicated in active liver disease. In patients with stable, chronic liver disease, fluvastatin must be used with extreme caution and frequent monitoring of liver enzymes.

> Important: Special populations require individualized medical assessment and more frequent monitoring to ensure the safest possible treatment outcomes.

Fluvastatin is a competitive inhibitor of HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate. Mevalonate is the precursor for cholesterol, ubiquinone (CoQ10), and dolichols. By inhibiting this pathway, fluvastatin reduces hepatic cholesterol content. This triggers a homeostatic response where the liver upregulates LDL receptors, increasing the clearance of LDL and VLDL particles from the systemic circulation. This results in a significant reduction in total cholesterol and LDL-C.

The therapeutic effect of fluvastatin is dose-dependent. A reduction in LDL cholesterol is typically observed within 1 to 2 weeks of starting therapy, with the maximum effect reached within 4 to 6 weeks. Continuous administration is required to maintain the lipid-lowering effect. If the drug is discontinued, cholesterol levels generally return to baseline within a few weeks.

| Parameter | Value |

|---|---|

| Bioavailability | ~24% |

| Protein Binding | >98% (primarily albumin) |

| Half-life | 1.2 - 3 hours (Immediate Release) |

| Tmax | 0.5 - 1.0 hours (Capsules); 3 hours (XL) |

| Metabolism | Primarily Hepatic (CYP2C9) |

| Excretion | Fecal (~95%), Renal (<5%) |

• Molecular Formula: C24H25FNO4Na (Sodium salt)
• Molecular Weight: 433.45 g/mol
• Solubility: Soluble in water, ethanol, and methanol.
• Description: Fluvastatin sodium is a white to pale yellow, hygroscopic powder. It is a racemate; however, the lipid-lowering activity resides in the (3R, 5S)-isomer.

Fluvastatin belongs to the HMG-CoA reductase inhibitor class (statins). Within this class, it is categorized as a synthetic statin and a Type II statin, distinguished by its fluorinated phenyl group. Compared to other statins like atorvastatin or rosuvastatin, fluvastatin is considered a low-to-moderate potency statin, making it a preferred choice for patients who require modest LDL reduction or those who are sensitive to the side effects of more potent statins.